Clinical Trials
2 trialsNCT03737981 2026-05-29
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06249880 2026-03-09
Pediatric Normative Markerless Movement Analysis
MultiCare Health System Research Institute
Recruiting